CARMA Therapeutics Launched to Develop New Cellular Therapies

CARMA Therapeutics was launched by co-founders Saar Gill, MD, PhD and Michael Klichinsky, PharmD through UPstart within PCI Ventures at the University of Pennsylvania to commercialize new cellular therapies based on chimeric antigen receptor targeting of macrophages. The company is located in Philadelphia, PA.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s